miRNA and Palladium Nanoparticles for Label-Free Cancer Testing

Laura Ruvuna is guest web writer for Analyst. She is currently a PhD student at Northwestern University, Evanston, Illinois, USA.

Schematic steps for biosensor detecting mRNAs

Short non-coding single stranded nucleotides known as microRNA (miRNA) have become important biomarkers due to their up- and down-regulated expression in certain cancers.

Jing Han and colleagues at Southwest University, China, targeted miRNAs using an electrochemical-based biological sensor containing palladium nanoparticles. A multilayer film coated the glass electrodes in order to bind the palladium particles, and then catalyzed hydrogen peroxide to enhance the signal of the miRNA binding. Using a model of miRNA overexpressed in several diseases, miRNA-155, they detected even low concentrations in blood serum samples previously prepared and demonstrated the high reproducibility and adaptability of this assay for a variety of other biomarkers.

To read more about this study, access to the link below. This paper will be free to read until January 24th.

A novel label-free electrochemical microRNA biosensor using Pd nanoparticles as enhancer and linker
Xiaoyan Wu ,  Yaqin Chai ,  Ruo Yuan ,  Huilan Su and Jing Han
Analyst, 2013, Advance Article
DOI: 10.1039/C2AN36506E

Digg This
Reddit This
Stumble Now!
Share on Facebook
Bookmark this on Delicious
Share on LinkedIn
Bookmark this on Technorati
Post on Twitter
Google Buzz (aka. Google Reader)